These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 25568284)

  • 1. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB; Amsterdam JD; Wintering N; Ploessl K; Swanson RL; Shults J; Alavi A
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantifying midbrain serotonin transporter in depression: a preliminary study of diagnosis and naturalistic treatment outcome.
    Tsai HC; Lin SH; Chen PS; Chang HH; Lee IH; Yeh TL; Chen KC; Chiu NT; Yao WJ; Liao MH; Yang YK
    Pharmacopsychiatry; 2015 Mar; 48(2):58-64. PubMed ID: 25626060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of SSRI treatment response in major depression based on serotonin transporter interplay between median raphe nucleus and projection areas.
    Lanzenberger R; Kranz GS; Haeusler D; Akimova E; Savli M; Hahn A; Mitterhauser M; Spindelegger C; Philippe C; Fink M; Wadsak W; Karanikas G; Kasper S
    Neuroimage; 2012 Nov; 63(2):874-81. PubMed ID: 22828162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower serotonin transporter binding potential in the human brain during major depressive episodes.
    Parsey RV; Hastings RS; Oquendo MA; Huang YY; Simpson N; Arcement J; Huang Y; Ogden RT; Van Heertum RL; Arango V; Mann JJ
    Am J Psychiatry; 2006 Jan; 163(1):52-8. PubMed ID: 16390889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter occupancy induced by paroxetine in patients with major depression disorder: a 123I-ADAM SPECT study.
    Catafau AM; Perez V; Plaza P; Pascual JC; Bullich S; Suarez M; Penengo MM; Corripio I; Puigdemont D; Danus M; Perich J; Alvarez E
    Psychopharmacology (Berl); 2006 Dec; 189(2):145-53. PubMed ID: 17033844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.
    Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV
    J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Cannon DM; Ichise M; Rollis D; Klaver JM; Gandhi SK; Charney DS; Manji HK; Drevets WC
    Biol Psychiatry; 2007 Oct; 62(8):870-7. PubMed ID: 17678634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower availability of midbrain serotonin transporter between healthy subjects with and without a family history of major depressive disorder - a preliminary two-ligand SPECT study.
    Hsieh PC; Chen KC; Yeh TL; Lee IH; Chen PS; Yao WJ; Chiu NT; Chen CC; Liao MH; Yang YK
    Eur Psychiatry; 2014 Sep; 29(7):414-8. PubMed ID: 24439516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
    Lehto SM; Tolmunen T; Kuikka J; Valkonen-Korhonen M; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Lehtonen J
    Neurosci Lett; 2008 Aug; 441(3):291-5. PubMed ID: 18588943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
    Ruhé HG; Booij J; Reitsma JB; Schene AH
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder.
    Miller JM; Oquendo MA; Ogden RT; Mann JJ; Parsey RV
    J Psychiatr Res; 2008 Oct; 42(14):1137-44. PubMed ID: 18331740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
    Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitination of serotonin transporter in lymphoblasts derived from fluvoxamine-resistant depression patients.
    Mouri A; Ikeda M; Koseki T; Iwata N; Nabeshima T
    Neurosci Lett; 2016 Mar; 617():22-6. PubMed ID: 26845564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced midbrain serotonin transporter availability in drug-naïve patients with depression measured by SERT-specific [(123)I] nor-beta-CIT SPECT imaging.
    Joensuu M; Tolmunen T; Saarinen PI; Tiihonen J; Kuikka J; Ahola P; Vanninen R; Lehtonen J
    Psychiatry Res; 2007 Feb; 154(2):125-31. PubMed ID: 17289353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study of serotonin transporter availability and SLC6A4 gene polymorphisms in patients with major depression.
    Ho PS; Ho KK; Huang WS; Yen CH; Shih MC; Shen LH; Ma KH; Huang SY
    Psychiatry Res; 2013 Jun; 212(3):216-22. PubMed ID: 23149035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.